생명공학의약품의 약동학 시험 지침 개발 연구

Title
생명공학의약품의 약동학 시험 지침 개발 연구
Other Titles
Development of Guidance on the Pharmacokinetic Studies of Therapeutic Biologics
Author(s)
이혜원[이혜원]임미선[임미선]성숙진[성숙진]이주미[이주미]박성민[박성민]노금한[노금한]박성호[박성호]김은정[김은정]강원구윤영란[윤영란]
Keywords
biologics; pharmacokinetics; guidance; bioanalytics
Issue Date
201203
Publisher
한국임상약학회
Citation
한국임상약학회지, v.22, no.1, pp.21 - 29
Abstract
Modern biologics are biotechnology-derived therapeutics, including recombinant therapeutic proteins like monoclonal antibodies, cytokines and tissue growth factors. Although the pharmacokinetics of therapeutic biologics should be evaluated based on the same general principles as small molecules, careful considerations should be given to bioanalytics and pharmacokinetics when designing pharmacokinetic studies of biologics during their drug development, due to their different physicochemical properties compared with small molecules. The aim of this study was to develop a draft guidance on pharmacokinetic studies of therapeutic biologics in clinical studies. All the elements outlined in the current Food and Drug Administration (FDA), European Medicinal Agency (EMEA), and International Conference on Harmonisation (ICH) guidelines and regulations, and the related literatures previously published were searched and evaluated. In this draft guidance, the specific problems related to the pharmacokinetics of therapeutic biologics that need special consideration during drug development process were addressed, and differences in pharmacokinetic characteristics between biologics and small molecules affecting the content of the development programme were presented.
URI
http://hdl.handle.net/YU.REPOSITORY/29372
ISSN
1226-6051
Appears in Collections:
약학대학 > 약학부 > Articles
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE